|
NICE issues new draft treatment guidance for patients with diabetic macular edema
|
|
|
|
pSivida
: 17 June, 2013 (Company News) |
| The United Kingdom's National Institute for Health and Care Excellence (NICE) issues draft guidance recommending pSivida's ILUVIEN for the treatment of pseudophakic patients (those who have undergone prior cataract surgery) with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|